We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
-3.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$58.4M
AUM Growth
-$35.8M
Cap. Flow
-$13.1M
Cap. Flow %
-22.36%
Top 10 Hldgs %
41.11%
Holding
109
New
27
Increased
13
Reduced
25
Closed
40

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$2.5M
2
NXPI icon
NXP Semiconductors
NXPI
+$2.09M
3
WDC icon
Western Digital
WDC
+$1.49M
4
CI icon
Cigna
CI
+$1.16M
5
NVS icon
Novartis
NVS
+$962K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.44M
2
HUM icon
Humana
HUM
+$2.73M
3
BABA icon
Alibaba
BABA
+$2.34M
4
DIS icon
Walt Disney
DIS
+$1.74M
5
PYPL icon
PayPal
PYPL
+$1.72M

Sector Composition

Rank Sector Weight
1 Healthcare 53.01%
2 Technology 26.41%
3 Miscellaneous 14.9%
4 Financials 2.04%
5 Communication Services 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZBH icon
1
Zimmer Biomet
ZBH
$19.2B
$2.43M 4.16%
18,219
-3,832
-17% -$495K
NXPI icon
2
NXP Semiconductors
NXPI
$56.4B
$2.23M 3.83%
+20,473
New +$2.09M
MCHP icon
3
Microchip Technology
MCHP
$39.6B
$2.23M 3.82%
47,992
+3,280
+7% +$149K
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
$2.17M 3.71%
+22,136
New +$2.5M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$12.5B
$1.98M 3.39%
29,341
+3,731
+15% +$287K
GILD icon
6
Gilead Sciences
GILD
$181B
$1.81M 3.09%
28,502
+7,400
+35% +$484K
TWLO icon
7
Twilio
TWLO
$36.5B
$1.74M 2.97%
15,783
+7,139
+83% +$926K
PEN icon
8
Penumbra
PEN
$12.7B
$1.69M 2.89%
12,558
+3,898
+45% +$603K
WDC icon
9
Western Digital
WDC
$166B
$1.57M 2.69%
+34,829
New +$1.49M
INTU icon
10
Intuit
INTU
$97.9B
$1.52M 2.61%
5,722
-441
-7% -$121K
CRM icon
11
Salesforce
CRM
$211B
$1.49M 2.55%
10,032
-7,020
-41% -$1.07M
GDDY icon
12
GoDaddy
GDDY
$12.4B
$1.45M 2.48%
21,910
-1,475
-6% -$100K
ARNA
13
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.32M 2.26%
28,877
+10,718
+59% +$602K
IQV icon
14
IQVIA
IQV
$43.1B
$1.28M 2.19%
8,567
-975
-10% -$152K
XBI icon
15
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$1.25M 2.14%
+16,400
New +$1.36M
AGN
16
DELISTED
Allergan plc
AGN
$1.24M 2.12%
7,374
-21,143
-74% -$3.44M
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
$1.23M 2.11%
4,757
-2,442
-34% -$674K
ALNA
18
DELISTED
Allena Pharmaceuticals
ALNA
$1.12M 1.92%
284,285
-3,566
-1% -$15.3K
CI icon
19
Cigna
CI
$73.7B
$1.08M 1.85%
+7,132
New +$1.16M
MSFT icon
20
Microsoft
MSFT
$3.81T
$1.03M 1.76%
7,383
-3,092
-30% -$425K
IRTC icon
21
iRhythm Holdings
IRTC
$3.96B
$946K 1.62%
12,761
+5,089
+66% +$394K
NVS icon
22
Novartis
NVS
$292B
$927K 1.59%
+10,711
New +$962K
HCA icon
23
HCA Healthcare
HCA
$90.5B
$903K 1.55%
7,500
-4,060
-35% -$525K
EW icon
24
Edwards Lifesciences
EW
$52B
$818K 1.4%
11,157
-11,691
-51% -$821K
SYK icon
25
Stryker
SYK
$127B
$806K 1.38%
3,728
-4,139
-53% -$888K
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2019 Portfolio in Review

As of Q3 2019, Partner Investment Management held 109 positions worth $58.4M, down 38% from $94.2M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Partner Investment Management withdrew a net $13.1M in Q3 2019, closing 40 positions and reducing 25 holdings. Its most notable exit was Humana, an estimated $2.73M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 46% a quarter earlier, followed by Technology and Miscellaneous.

Against the trend, Partner Investment Management opened a new position in Alexion Pharmaceuticals worth $2.17M.

  • Partner Investment Management's largest Q3 2019 buy was Alexion Pharmaceuticals: 22,136 shares worth $2.17M.
  • Partner Investment Management added most to Twilio in Q3 2019, an estimated $926K increase.
  • Partner Investment Management's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $3.44M.
  • Partner Investment Management fully exited Humana in Q3 2019, selling an estimated $2.73M.
  • Partner Investment Management's ten largest holdings make up 41% of its $58.4M portfolio in Q3 2019.
  • Partner Investment Management opened 27 new positions and closed 40 in Q3 2019.
  • Partner Investment Management's portfolio value fell 38% quarter-over-quarter to $58.4M.

Based on Partner Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.